94 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
22 Apr 24
Report of Foreign Private Issuer
8:02am
and confirmation by the independent Data and Safety Monitoring Board. In addition to evaluating safety, the blinded randomized stage is statistically-powered
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Apr 24
Report of Foreign Private Issuer
8:00am
following the completion of the safety run-in stage and confirmation by the independent Data and Safety Monitoring Board. In addition to evaluating safety
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
participated in several advisory boards for sepsis multinational trials, independent clinical evaluation committees and adjudication committees. Dr
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
Exhibit 99.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-8, F-3
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
AS OF DECEMBER 31, 2023
INDEX
Page
Report of Independent Registered Public Accounting Firm
F-2
Consolidated Balance Sheets
F-5
Consolidated Statements … to Consolidated Financial Statements
F-9
F-1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of ENLIVEX
6-K
EX-99.1
fps7 pt6ey32
17 Jan 24
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
tjd rj934bwjab
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.2
4ykph wkivxtsp4
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
3kjna28asl960j
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
uic6v3z8r02ln7
17 Apr 23
Enlivex Appoints Andrew Singer to its Board of Directors
8:03am
6-K
EX-99.1
lv6j35fa
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.2
9iab663sm0zv27nd
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
xifzftf73
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
5q8eees7eg4zcn
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
5ksvo
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
pgm05mm4qy11fosj
25 May 22
Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant
8:05am
F-3
EX-23.1
qohko12
29 Apr 22
Shelf registration (foreign)
8:14am
F-3
efbcxmv4typgdy5v
29 Apr 22
Shelf registration (foreign)
8:14am